Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Liabilities (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Total Liabilities data on record, last reported at $164.8 million in Q4 2025.

  • For Q4 2025, Total Liabilities rose 46.41% year-over-year to $164.8 million; the TTM value through Dec 2025 reached $164.8 million, up 46.41%, while the annual FY2025 figure was $164.8 million, 46.41% up from the prior year.
  • Total Liabilities reached $164.8 million in Q4 2025 per ORGO's latest filing, up from $123.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $202.0 million in Q2 2022 and bottomed at $99.3 million in Q1 2025.
  • Average Total Liabilities over 5 years is $168.2 million, with a median of $180.1 million recorded in 2024.
  • The widest YoY moves for Total Liabilities: up 46.41% in 2025, down 44.96% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $201.9 million in 2021, then dropped by 9.03% to $183.7 million in 2022, then fell by 1.27% to $181.4 million in 2023, then plummeted by 37.93% to $112.6 million in 2024, then soared by 46.41% to $164.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $164.8 million in Q4 2025, $123.8 million in Q3 2025, and $99.9 million in Q2 2025.